Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jian-Ri Li

6PUBLICATIONS
20CO-AUTHORS
Infectious diseasesPharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Jun 01, 2026
Risk factors for mortality in prostatic abscess: Insights into patient characteristics and drainage practices.

|Mar 09, 2023
Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics.

Chen-Hsun Hsueh, Li-Wen Chang, Kun-Yuan Chiu

|Oct 14, 2022
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on <i>FGFR1</i>/<i>3</i> mRNA Expression.

Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt

|Jun 28, 2022
Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.

Jian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen

|Jun 23, 2022
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).

Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov

|Oct 19, 2018
Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma.

Jian-Ri Li, Kun-Yuan Chiu, Yen-Chuan Ou

Pageof 1

Frequent Collaborators

1 joint publications

Jonathan E Rosenberg

1 joint publications

Se Hoon Park

1 joint publications

Tu V Dao

1 joint publications

Daniel Castellano

1 joint publications

Hannah Dry

1 joint publications

Dean F Bajorin

1 joint publications

Kun-Yuan Chiu

1 joint publications

Cora N Sternberg

1 joint publications

Daniel P Petrylak

1 joint publications

Joaquim Bellmunt

Frequent Collaborators

1 joint publications

Jonathan E Rosenberg

1 joint publications

Se Hoon Park

1 joint publications

Tu V Dao

1 joint publications

Daniel Castellano